BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36357462)

  • 1. Intraprocedural endothelial cell seeding of arterial stents via biotin/avidin targeting mitigates in-stent restenosis.
    Alferiev IS; Hooshdaran B; Pressly BB; Zoltick PW; Stachelek SJ; Chorny M; Levy RJ; Fishbein I
    Sci Rep; 2022 Nov; 12(1):19212. PubMed ID: 36357462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis.
    Park KS; Kang SN; Kim DH; Kim HB; Im KS; Park W; Hong YJ; Han DK; Joung YK
    Acta Biomater; 2020 Jul; 111():91-101. PubMed ID: 32434081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients.
    Szük T; Fejes Z; Debreceni IB; Kerényi A; Édes I; Kappelmayer J; Nagy B
    Platelets; 2016 Jul; 27(5):410-9. PubMed ID: 26765134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial).
    Wojakowski W; Pyrlik A; Król M; Buszman P; Ochała A; Milewski K; Smolka G; Kawecki D; Rudnik A; Pawłowski T; Jadczyk T; Wyderka R; Cybulski W; Dworowy S; Tendera M
    Minerva Cardioangiol; 2013 Jun; 61(3):301-11. PubMed ID: 23681133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
    Curcio A; Torella D; Indolfi C
    Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
    Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
    Trials; 2012 May; 13():55. PubMed ID: 22559260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Low Endothelial Shear Stress After Stent Implantation on Subsequent Neointimal Hyperplasia and Clinical Outcomes in Humans.
    Shishido K; Antoniadis AP; Takahashi S; Tsuda M; Mizuno S; Andreou I; Papafaklis MI; Coskun AU; O'Brien C; Feldman CL; Saito S; Edelman ER; Stone PH
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27628570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation.
    Mizia-Stec K; Gasior Z; Haberka M; Mizia M; Chmiel A; Janowska J; Holecki M; Mielczarek M; Zahorska-Markiewicz B
    Kardiol Pol; 2009 Jan; 67(1):9-17; discussion 18. PubMed ID: 19253185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.
    Sharif F; Hynes SO; McCullagh KJ; Ganley S; Greiser U; McHugh P; Crowley J; Barry F; O'Brien T
    Gene Ther; 2012 Mar; 19(3):321-8. PubMed ID: 21716298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis.
    Kim C; Lee SG; Lim S; Jung M; Kwon SP; Hong J; Kang M; Sohn HS; Go S; Moon S; Lee SJ; Kim JS; Kim BS
    ACS Biomater Sci Eng; 2022 May; 8(5):1921-1929. PubMed ID: 35416659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries.
    Fishbein I; Alferiev I; Bakay M; Stachelek SJ; Sobolewski P; Lai M; Choi H; Chen IW; Levy RJ
    Circulation; 2008 Apr; 117(16):2096-103. PubMed ID: 18413497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model.
    Chang HK; Kim PH; Kim DW; Cho HM; Jeong MJ; Kim DH; Joung YK; Lim KS; Kim HB; Lim HC; Han DK; Hong YJ; Cho JY
    Exp Mol Med; 2018 Sep; 50(9):1-14. PubMed ID: 30174328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents.
    Tang C; Wang G; Wu X; Li Z; Shen Y; Lee JC; Yu Q
    J Vasc Surg; 2011 Feb; 53(2):461-71. PubMed ID: 21129910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.
    De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
    Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis.
    George J; Herz I; Goldstein E; Abashidze S; Deutch V; Finkelstein A; Michowitz Y; Miller H; Keren G
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):e57-60. PubMed ID: 14615392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.